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response and enhances susceptibility to secondary 
infections, which increases the risk of  sepsis and septic 
complications (ARDS, MOF).[4,5] Although the incidence 
of  post-traumatic sepsis in the hospital has decreased in the 
past two decades,[6] the mortality (between 19.5% and 23%) 
of  septic trauma patients is still high.[6,7] Early diagnosis and 
treatment of  these patients with antibiotics can improve the 
prognosis and reduce mortality.[8-11]
Diagnosis of  the pathogen that causes sepsis requires 
bacterial culture,[12] but it is often delayed due to long 
culture times (24 h to 48 h). Furthermore, a third or more 
of  septic patients with infections have cultures that are 
negative for bacteria.[11,13-17] This may contribute to the high 
mortality. Identification of  the factors associated with the 
development of  post-traumatic sepsis may help in the early 
prediction of  the occurrence of  this complication so that 
timely interventions could be performed to improve the 
outcomes. Research on some factors, such as biomarkers, 
patient demographics and injury characteristics have 
revealed some elements that are predictable in post-
traumatic sepsis. Here, we review these predictors and risk 
factors of  post-traumatic sepsis.
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A B S T R A C T
Trauma is one of the leading causes of death worldwide. Approximately 39.5% of deaths occur in the hospital, and the mortality 
rate of delayed death caused by septic complications is still high. Early prediction of the development of sepsis can help promote 
early intervention and treatment for patients and contribute to improving patient outcomes. Thus so far, biomarkers, patient demo-
graphics and injury characteristics are the main methods used for predicting sepsis in trauma patients. However, studies that verify 
their predictive value are limited, and the results are still controversial. More work should be conducted to explore more eﬃ  cient 
and accurate ways to predict post-traumatic sepsis. 
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Introduction
Trauma is still a leading cause of  death worldwide, with a 
mortality of  5,800,000 people per year.[1] Fifty-three percent 
of  deaths that happen after trauma occur at the scene of  
the accident, 7.5% occur in the emergency department, 
and 39.5% occur in the hospital.[2] Patients who survive 
the early period after trauma may suffer morbidity and 
complications in succeeding treatment phases.[3] The initial 
injury and subsequent operative treatments promote a 
pro-inflammatory response, which is exaggerated and may 
cause organ injury (acute respiratory distress syndrome 
[ARDS] and multiple organ failure [MOF]).[4] Meanwhile, 
an anti-inflammatory response is involved in reducing 
the potentially harmful effects of  the pro-inflammatory 
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Biomarkers
According to the Biomarkers Definitions Working Group, a 
biomarker is a characteristic that is objectively measured and 
evaluated as an indicator of  normal biological processes, 
pathogenic processes or pharmacologic responses to a thera-
peutic intervention.[18] In other words, biomarkers are 
tools to measure biologic homeostasis that give standard 
to what is normal and provide a quantifiable method for 
predicting or detecting what is abnormal.[19] The ideal bio-
marker for sepsis should have a high sensitivity allowing 
for early diagnosis and would be specific for pathogenic 
microorganisms to allow appropriate therapy.[20] It has been 
reported that more than 80 molecules have been proposed 
as useful biomarkers of  sepsis,[21] and to date, the number 
has increased to 178 or more.[22] To be considered a valid 
biomarker, 3 aspects must be present: (1) proving that the 
test truly measures a particular molecular species or its 
relevant biological activity; (2) proving that measurement 
of  the biomarker discriminates patients with a disease from 
those who are without the disease; (3) proving that mea-
surement of  the biomarker can inform a clinical decision 
that can improve patient outcomes.[23] Here, we list some 
representable candidates among the potential biomarkers 
of  post-traumatic sepsis.
Procalcitonin (PCT)
PCT is a precursor of  the hormone calcitonin, which is 
codified by the CALC-I gene located on chromosome 
11 and is produced and secreted by parafollicular C cells 
of  the thyroid to sustain calcium homeostasis.[24] PCT 
has been shown to be a marker of  bacterial infection 
and sepsis[25,26] as PCT is released systemically from 
various types of  cells outside the thyroid as a response 
to bacterial infection.[27] On the condition of  systemic 
bacterial infection or by stimulation with endotoxin or 
proinflammatory cytokines such as tumor necrosis factor 
(TNF)-α, interleukin (IL)-6 and IL-1, PCT levels increase 
1,000 times within a few hours.[28,29] The half-life of  PCT, 
approximately 22 h, is another characteristic that can 
be used as a biomarker for bacterial infection. Its levels 
show a rapid decrease when infection is resolved, whereas 
many other inflammatory biomarkers still have high levels 
during the acute-phase response.[28] For predicting post-
traumatic sepsis, studies have shown the rapid kinetics 
of  PCT, with levels peaking at 24-48 h after trauma and 
rapid decrease in non-complicated patients, whereas 
with constant high levels in septic patients.[4] Continuous 
high levels or sec ondary increases of  PCT are predictors 
of  sepsis.[27,28,30-34] PCT as a biomarker is useful in the 
prediction and early diagnosis of  sepsis in trauma patients. 
Currently, PCT is already used in clinical practice, and 
it is used to guide antibiotic therapy in patients with 
lower respiratory tract infections or other infections such 
as fungal infections, postoperative fever and suspected 
bloodstream infections.[35]
C-reactive protein (CRP)
CRP belongs to the acute phase protein family. Each one 
is made of  5 protomers of  206 amino acid residues, and 
belongs to the pentraxin family of  calcium-dependent 
ligand-binding plasma proteins.[36] CRP is mainly synthe-
sized in the hepatocytes, and its transcription is reduced 
by the cytokine IL-6, which is predominantly released by 
macrophages in response to various types of  systemic in-
flammation, including infections or trauma.[36-38] Therefore, 
it is a sensitive marker of  inflammation and tissue damage. 
The half-life of  CRP is 19 h.[39] Serum CRP is used as a 
biomarker because of  the rapid concentrations that increase 
in response to inflammation, the shorter half-life and the 
widely available ine xpensive test. Many researchers have 
explored the predictive value of  CRP for post-traumatic 
sepsis, but the results are unsatisfactory. Both prospective 
studies and retrospective studies have reported no predic-
tive power of  CRP for sepsis in trauma patients.[4,28,30-32,40-43]
IL-6
IL-6 is a glycoprotein synthesized by various types of  cells 
including T- and B-cells and endothelial cells. Other cy-
tokines (IL-1, TNF-α), viruses and bacterial components, 
such as lipopolysaccharide (LPS), induce the production of  
IL-6. IL-6 induces hepatic production of  acute-phase pro-
teins such as CRP and complement factors, regulation of  
B- and T-lymphocytes, differentiation of  cytotoxic T-cells, 
and an enhanced activity of  natural killer (NK) cells.[44] 
Its release is triggered by tissue damage or infection. It is 
a cytokine involved in both pro -inflammatory and anti-
inflammatory responses.[45] IL-6 has a rapid onset, peaking 
within 2 h after the infectious stimulus.[46] The results of  
studies on the predictive value of  IL-6 for post-traumatic 
sepsis are controversial. Some studies have found that IL-6 
is able to discriminate trauma patients prone to sepsis[31,32] 
while others have shown no correlation between the IL-6 
levels and sepsis development.[42,43,47-50]
IL-10
IL-10 is a protein produced by T-lymphocytes, B-lym-
phocytes, macrophages and dendritic cells (DC).[51] It is 
an anti-inflammatory cytokine playing a role in counter 
inflammatory and aut oimmune pathologies.[52] IL-10 
downregulates MH C class II and co-stimulatory molecules 
B7-1/B7-2 expression on monocytes and macrophages, 
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inhibiting their antigen-presenting function, and limits the 
synthesis of  pro-inflammatory cytokines ( IL-1, TNF-α) 
as well as decreases cytokine production of  Th-1 cells.[51]
IL-10 peaks quickly, within a few hours (4 h) following 
trauma, and the levels decrease rapidly in all patients (the 
first day after trauma).[53,54] IL-10 levels have been shown 
to be significantly higher in patients who develop sepsis at 
the point of  admission.[4,53-56]
Neopterin
Neop terin is a pteridine produced by monocytes or mac-
rophages upon stimulation with interferon (IFN)-γ and is 
then released into body circulation.[57] Neopterin is useful for 
the diagnosis of  bacterial and viral infections and systemic 
inflammation. In addition, increased levels of  neopterin are 
associated with endothelial damage, organ dysfunction and 
sepsis.[58] Among the studies performed on predicting post-
traumatic sepsis, neopterin levels have shown no significant 
difference between patients who developed and did not 
develop sepsis.[42,58-60]
Pancreatic stone protein/regenerating protein (PSP/reg)
PSP/reg is a lectin-binding acute phase protein and was 
initially found in patients with pancrea titis.[61] PSP/reg acts 
as an acute phase protein causing the activation of  leuko-
cytes and can also be observed in other cells outside the 
pancreas.[32] Its release is reduced by IL-6 following tissue 
injury.[62] PSP/reg levels can predict and distinguish septic 
complications in post-traumatic patients.[32]
IL-1
IL-1 is an import ant mediator of  innate immunity and in-
flammation. It can significantly lengthen the lifespan and 
activate the function of  neutrophils and macrophages in 
response to infections.[63] Its effects on the central nervous 
system cause fever, the elevated temperature leads to an 
increased migration of  leukocytes. Few studies demonstrate 
evidence of  the predictive power of  IL-1 for sepsis after 
trauma, except Menges et al.[55] who reported the positive 
correlation between IL-1 and sepsis.
Amino-terminal pro-peptide (NT-proCNP)
NT-proCNP is a part of  the natriuretic peptide fam-
ily and was first identified in 1990. CNP participates in 
physiological processes such as bone gr owth, reproduc-
tion, nerve growth, and re-endothelialization.[64] ProCNP 
protein is a precursor of  CNP. As a cleavage product of  
proCNP, Amino-terminal pro-C-type natriuretic peptide 
(NT-proC NP) is the N-terminal fragment of  the C-type na-
triuretic peptide precursor.[65] The amounts of  NT-proCNP 
are equal to CNP in huma n plasma and NT-proCNP is 
considered to be a more reliable indicator of  the extent of  
CNP synthesis.[65] Results of  a study show that the levels 
of  circulating NT-proCNP can discriminate poly trauma 
patients without traumatic brain injury who develop sepsis 
from those who do not.[66]
Polymorphonuclear elastase (PMNE)
In healthy adults, polymorphonuclear (PMN) circulates 
during the resting state and can be activated following major 
trauma.[67] PMN is the main effector cell of  the inflamma-
tory response post-trauma and it produces and releases toxic 
reactive oxygen species. PMN activation and inflammatory 
response post-trauma may be reflected in serum e lastase 
levels.[67] Some studies have shown the difference in PMN 
elastase between patients with and without infection or sep-
sis[47,59], while others have shown that it has no correlation 
with post-traumatic infective complications.[42,43]
Lactate clearance
Persistent occult hypoperfusion is a risk factor for infections 
following trauma,[68] and lactate clearance is proposed as a 
measure of  early sepsis resuscitation effectiveness.[69] Thus, 
lactate clearance can be a biomarker of  sepsis. During the 
first 12-24 h, the lactate clearance is associated with post-
traumatic sepsis.[31,68]
IL-18
As a member of  the IL-1 cytokine family, IL-18, which 
is produced by a variety of  cells including Kuppfer cells, 
monocytes, dendritic cells (DC), macrophages, and so on, 
induces the production of  IFN-γ and other cytokines. It is 
found to have high levels in sepsis patients compared to 
healthy people.[70] Mommsen et al.[58] has proposed IL-18 
concentrations as early markers for post-traumatic com-
plications such as sepsis and MODS.
Monocyte Human Leukocyte Antigen DR (mHLA-DR)
Human leukocyte antigen-DR (HLA-DR) is a member of  
the MHC class II system. HLA-DR is expressed in antigen 
presenting cells (APC) including monocytes, macrophages, 
dendritic cells and B lymphocytes.[71] Low expression of  
HLA-DR on circulating monocytes (mHLA-DR) is reported 
as an indicator of  post-trauma immune suppression.[71] Stud-
ies show that the decreased level of mHLA-DR is a biomarker 
of  sepsis development after major trauma.[72,73]
Other biomarkers for sepsis following trauma
Some potential biomarkers, such as Toll-like receptor 
(TLR)-9,[74] PMN cluster of  differentiation (CD) 11b,[49] 
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Soluble factor associated suicide (FAS) (sFAS),[47] Group-
specific component globulin (Gc-globulin),[75] kynurenine 
values and kynurenine-tryptophan ratios,[76] and the soluble 
thrombomodulin (s-TM) level,[77] have also been reported to 
have predictive abilities for post-traumatic sepsis. TNF-α, an 
important cytokine, has been shown to have no sufficiently 
predictive value for sepsis development after trauma.[50]
Evaluation of  biomarkers of  post-traumatic sepsis is il-
lustrated in Table 1.
Until now, many biomarkers have been proposed in the field 
of  sepsis. However, there are only a few biomarkers that 
have been shown to be useful for predicting post-traumatic 
sepsis. Among the biomarkers for sepsis following trauma, 
PCT is the most extensively investigated biomarker, and the 
results show good application in predicting this complica-
tion. However, others, such as CRP, though many studies 
have been performed on it, show no predictive power for 
trauma patients. For some biomarkers such as IL-6 and 
PMNE, the results are controversial. There are also some 
biomarkers such as IL-1 and IL-18, that show the predictive 
value of  sepsis post-trauma, but the studies are few and the 
results need further evidence to support this. Traumatic 
injuries cause great changes in the immunological and 
neurohormonal environments, which then affect physi-
ological processes. After trauma, the innate immune system 
is activated, and many pro-inflammatory cytokines, such 
as TNF-α, IL-1 and IL-6 are released, leading to systemic 
inflammation. Activation of  neutrophils and endothelial 
cells can cause endothelium and tissue damage. To counter 
these disadvantages, anti-inflammatory cytokines, such as 
IL-10, are released, leading to immune suppression and 
increased risk of  secondary infections. The primary cyto-
kines TNF-α and IL-1 can induce the release of  following 
cytokines including IL-6 and IL-8. IL-6 again promotes the 
production of  acute phase proteins such as PCT and CRP.
Most of  the biomarkers illustrated above participate in the 
reaction of  systemic inflammation. However, post-trauma 
physiological processes may become more complicated due 
to immune function disorders caused by multiple trauma. 
For example, in the condition of abdominal or brain trauma, 
the kinetics of  biomarkers can be changed.[4] Therefore, 
more tests should be performed to verify the predictive value 
of  the present biomarkers and to find more biomarkers 
suitable to predict traumatic sepsis.
Patient demographics
Patient demographics including age, gender and race are 
risk factors associated with post-traumatic sepsis [Table 2].
Older age is an independent risk factor for sepsis following 
trauma.[3,6,78] This may be because elderly trauma patients 
have decreased cardiopulmonary function, poor nutritional 
status, and are susceptible to increased bleeding after inju-
ries. These factors may contribute to the disorder of  physi-
ological processes and immunologic function. In addition, 
elder trauma patients may have more pre-existing diseases 
than young patients, and the pre-existing diseases are also 
a risk factor for post-traumatic sepsis.[7]
Some studies have proposed the male gender as a predictor 
for sepsis post-trauma.[6,7,33,78] After trauma, the continuous 
increase in cytokines and the subsequent immunosuppres-
sion make the body prone to sepsis. A study performed on 
animals showed that pro-estrus females are not immunode-
pressed compared with male and ovariectomized mice after 
trauma.[79] Other test results have demonstrated that estrogen 
prod uces beneficial effects on immune and cardiovascular 
Table 1: Evaluation of biomarkers of post-traumatic sepsis
Biomarkers of post-traumatic sepsis Predictive value Study
PCT Yes [27,28,30-34]
CRP No [4,28,30-32,40-43]
IL-6 Controversial Yes [31,32]
No [42,43,47-50]
IL-10 Yes [4, 53-56]




PMNE Controversial Yes [47, 59]
No [42, 43]
Lactate clearance Yes [31, 68]
IL-18 Yes [58]
mHLA-DR Yes [72, 73]
TNF-α No [60]
TLR-9 Yes [74]




kynurenine values and kynurenine-
tryptophan ratio
Yes [76]
PCT = Procalcitonin, CRP = C-reactive protein, IL = Interleukin, PSP/reg = Pancreatic 
stone protein/regenerating protein, NT-proCNP = Amino-terminal pro-peptide, 
PMNE = Polymorphonuclear elastase, mHLA-DR = Monocyte Human Leukocyte 
Antigen DR, TNF-α = Tumor necrosis factor α, TLR-9 = Toll-like receptor-9, 
PMN CD11b = Polymorphonuclear cluster of differentiation 11b, sFAS = Soluble FAS, 
Gc-globulin = Group-specifi c component globulin, s-TM = Soluble thrombomodulin
Table 2: Risk factors of patient demographics associated with 
post-traumatic sepsis
Patient demographics Predictive value Study
Age Yes [3, 6, 78]
Gender Yes [6, 7, 33, 78]
Race Yes [78]
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function after trauma[80] by reducing the release of  cytokine 
production, such as TNF-α, and maintaining the immune 
response.[81] Thus, estrogen plays an important role in the 
gender dimorphism of post-traumatic sepsis.
African American race is reported as a risk factor of  sepsis 
following trauma.[78] However, there has been no extensive 
research conducted to investigate the role of  racial or 
ethnic factors in post-traumatic sepsis. More research is 
warranted to explore the association between ethnicity and 
this complication. 
Injury characteristics
Injury severity, mechanism of  injury, number of  injuries, 
hypotension on admission, and other injury characteristics 
are factors associated with post-traumatic sepsis.
Trauma can cause deficits in the immune system by depress-
ing the humoral and cell-mediated systems. After major 
trauma, the function of  lymphocytes is depressed. The 
neutrophil chemotaxis is decreased and monocyte antigen-
presenting capacity is impaired. There are also changes in 
complement components.[82] Different degrees of  trauma 
severity may lead to the different influences on immune 
function. The main measures of  injury severity are trauma-
scoring systems. Trauma scoring systems are divided into 
3 categories: Anatomical scoring systems, physiological 
scoring systems and combined scoring systems.[83]
The calculation of  most trauma scoring systems is time 
consuming and complicated. However, among the various 
scoring systems, the Injury Severity Score (ISS) and the 
New Injury Severity score (NISS) can be rapidly calculated 
and are most widely used in predicting outcomes of  trauma 
patients. The ISS and NISS are members of  anatomical 
scoring systems. The ISS is based on the Abbreviated In-
jury Scale (AIS) severity values, and it was first developed 
in 1974.[84] It is calculated as the sum of  the squares of  the 
highest AIS values from each of  the three most severely 
impaired body regions. It has some limitations, for example, 
it does not represent multiple injuries in the same body re-
gion and it considers injuries with an equal AIS score to be 
the same severity regardless of  the injured body region.[85]
The NISS was proposed by Osler et al. in 1997 to counter 
the limitations of  the ISS.[86] It is calculated as the sum of  
squares of  the three most severe injuries, regardless of  the 
body region injured. The ISS or NISS ranges from 1 to 75. 
Increasing injury severity measured by the ISS and NISS 
was associated with increased incidence of  sepsis.[3,6,7,78,87]
In addition to the ISS and NISS, the Glasgow coma scale 
(GCS), which assesses the level of  clinical consciousness 
is also a predictor of  sepsis.[6,7] The GCS was first de-
scribed by Teasdale and Jennett in 1974.[88] It is the sum of  
3 components that describes a patient’s best motor response, 
verbal response and eye opening to stimuli. It ranges from 
3 to 15, and the lower score the patient receives, the worse 
condition the patient is in. The GCS belongs to physiologi-
cal  scoring systems.[89]
The anatomy scoring systems such as the ISS and NISS 
represent the physical degeneration of  the body, and the 
physiological scoring systems, such as the GCS, stand for 
the physiological impairment caused by trauma. Compared 
to biomarkers, obtaining the indices of  these scoring sys-
tems is easier, earlier and cheaper. Further work may be 
needed to verify the accuracy of  the scoring systems and 
to explore whether the combination of  the two types of  
scoring systems can improve the predictive power for sepsis 
in trauma patients.
There are several injury characteristics reported as risk fac-
tors, such as number of  red blood cell units transfused,[3] 
hypotension on emergency department presentation[78] and 
number of  injuries.[6] However, studies on these factors are 
not common.
Conclusion
Early prediction of  sepsis development and early inter-
vention for patients at risk can decrease the morbidity 
and mortality after trauma. The prediction of  sepsis in 
trauma patients is still a challenge. Though approximately 
180 biomarkers for sepsis have been reported, the studies 
performed on the biomarkers for post-traumatic sepsis are 
few and the results are controversial. Trauma can affect 
immunologic function, and injury characteristics, such 
as injury severity and the number of  injuries, are risk 
factors that are associated with sepsis following trauma. 
To trauma patients, demographic variables, including 
age, gender and race are also risk factors. Obtaining the 
information of  injury characteristics and patient demo-
graphics is earlier, easier and cheaper than biomarkers, 
but the connection between these factors and the patho-
physiology of  sepsis is yet to be identified or clarified. 
Additional work is needed to verify the predictors and find 
more efficient and accurate ways that can better predict 
sepsis in trauma patients.
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